New diabetes therapeutics to steal ground from insulin therapies: GBI Research
Increased market diversification is expected due to patent expiries for major insulin products
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
Consolidated FDI policy 2017 – Implications on pharmaceuticals and healthcare sector
Rabindra Jhunjhunwala, Partner, Khaitan & Co and Sameer Sah, Associate Partner, Khaitan & Co share their insights on…
Type II diabetes market in South-East Asia set to experience strong growth
According to GBI Research, the type II diabetes market will hit $2.9 billion by 2023
Osteoarthritis 7MM market set to be worth $3.5 bn by 2026
The OA pipeline is rapidly evolving due to improved understanding of the disease’s pathophysiology and recent biomarker…
Global respiratory market to be worth $41.3 bn by 2023
According to GBI Research, patent expirations of the commercially successful Advair, Symbicort, Ventolin and Spiriva will allow…
Integrative cardiology: Where can Ayurveda contribute?
Dr M Vijayakumar, Clinical Professor, Adult Cardiology, Amrita Institute of Medical Sciences, Kochi, Kerala and Dr P Ram Manohar,…
Sustainable growth of pharma in India
The overuse of antibiotics and water pollution in India undermine the global pharma industry, says The Earth Security Report 2017.…
Evolving US generic market to plummet profitability levels of Indian pharma cos: Report
Indian pharma companies have to dexterously manoeuvre contingencies by expanding their existing pipeline and secure a dominant…
Innovation within dyslipidemia, heart failure and thrombosis set to reduce high CVD mortality rate
The GBI Research reflects efforts by the pharma industry to remedy the unmet need in treating this disease, which is associated…
APAC drug delivery devices market to reach $5.4 bn in 2023
Japan will emerge as the major country in APAC region contributing 64 per cent of the revenue in 2023
Global dermatology pipeline to see shift towards increased usage of biologics
42 per cent of the pipeline is in the preclinical stage, while 14 per cent is in the discovery stage and only three of drugs are…
Pharmacy profession is in a revolutionary phase at present
On the occasion of World Pharmacists Day, Abhay Kumar, President, Indian Pharmacists Association (IPA) speaks on various issues…
Past into the future?
Shailesh Gadre, MD, Gencoval Strategic Services shares his views on some of the key revolutionary/ evolutionary alterations in the…
Veg meds: Yay or nay?
The debate over gelatin capsules vs plant-based capsules (Cellulose) has garnered a lot of attention from all stakeholders of the…
AML market to surpass $1.5 bn by 2026
The acute myeloid leukemia (AML) market across the seven major countries (7MM) of the US, France, Germany, Italy, Spain, the UK,…
Nephrology and urology devices market growth predictions drive $57 billion investment
Asia-Pacific leads the market with a 43 per cent share, followed by North America and Europe
Global HER2-positive breast cancer market to face challenges from biosimilars through to 2025
The long-anticipated launch of oncology biosimilars in 2017 will be closely watched as drug makers expect to struggle with…
Pharma, medical and biotech witness 290 deals worth $89.9 bn in second quarter: Report
Mergermarket's Sector Trend Report on pharma, medical and biotech sectors reveal $166 billion that changed hands across 658 deals…
Global Clostridium difficile infections market to reach $1.7 bn by 2026
Major drivers of the growth include the projected launch of prophylactic options for the prevention of C. difficile,…
APAC colorectal cancer therapeutics market to reach $8 bn by 2023
Growth will be driven by the expected approval of promising therapies